This inventor holds 1 USPTO granted patent and 1 published patent application and 3 EPO patents. Top assignee: Vio Ag Pharmaceuticals S.a.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Petros Gkizis: Innovator in Pharmaceutical Chemistry
Introduction
Petros Gkizis is a notable inventor based in Salonika, Greece. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative approaches to drug synthesis. His work has implications for the development of important medications.
Latest Patents
One of Petros Gkizis's key patents is titled "One-pot organo-pseudocatalytic C—H activation approach for the preparation of vortioxetine and vortioxetine intermediate." This invention relates to a novel process for the preparation of vortioxetine and a key intermediate by employing a one-pot organo-pseudocatalytic C—H activation approach via hypervalent iodine chemistry. This patent highlights his expertise in creating efficient methods for drug synthesis.
Career Highlights
Throughout his career, Petros Gkizis has worked with several prominent companies in the pharmaceutical industry. Notably, he has been associated with Vio Ag Pharmaceuticals S.A. and Pharmathen S.A. His experience in these organizations has allowed him to apply his innovative ideas in practical settings, contributing to advancements in drug development.
Collaborations
Petros Gkizis has collaborated with several professionals in his field, including Theocharis V. Koftis and Efstratios Neokosmidis. These collaborations have fostered a productive exchange of ideas and have furthered the development of innovative pharmaceutical solutions.
Conclusion
In summary, Petros Gkizis is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in drug synthesis. His innovative approaches and collaborations continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile